News BerGenBio ASA

Equities

BGBIO

NO0010650013

Market Closed - Oslo Bors Other stock markets 10:45:00 2023-12-08 am EST			5-day change	1st Jan Change
0.218 ^NOK	-1.58%		+21.79%	-97.08%

Nov. 14	BerGenBio ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
Nov. 14	Transcript : BerGenBio ASA, Q3 2023 Earnings Call, Nov 14, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BerGenBio ASA: Grant of share options	Dec. 08	AQ
BerGenBio ASA - New share capital registered	Dec. 08	AQ
BerGenBio ASA: Approval and publication of prospectus	Dec. 07	AQ
BerGenBio ASA - Updated timeline for delivery of new shares	Dec. 07	AQ
BerGenBio ASA - Final results for the first exercise period for warrants issued in connection with rights issue	Nov. 30	AQ
BerGenBio ASA - Preliminary results for the first exercise period for warrants issued in connection with rights issue	Nov. 29	AQ
BerGenBio ASA - Last day of the first exercise period for warrants issued in connection with rights issue	Nov. 28	AQ
BerGenBio ASA - Information about the first exercise period for warrants issued in connection with rights issue	Nov. 24	AQ
BerGenBio ASA Mandatory notification of trade by primary insiders and close associates	Nov. 21	AQ
BerGenBio ASA - Commencement of the first exercise period for warrants issued in connection with rights issue	Nov. 15	AQ
BerGenBio ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Transcript : BerGenBio ASA, Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14	CI
BerGenBio Reports Third Quarter 2023 Financial Results	Nov. 14	AQ
BerGenBio ASA, Invitation to third quarter 2023 results webcast	Nov. 07	AQ
BerGenBio ASA: Invitation to third quarter 2023 results webcast	Nov. 06	AQ
BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC	Nov. 06	AQ
Bergenbio Announces Data from Biomarker Analyses in 2L Nsclc	Nov. 06	CI
BerGenBio Announces Poster Presentation at Upcoming ASH Meeting	Nov. 02	AQ
BerGenBio Announces Poster Presentation at Upcoming SITC Meeting	Oct. 31	AQ
New Data on BerGenBio's Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting	Oct. 23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

News BerGenBio ASA

Equities

BGBIO

NO0010650013

Summary

Filters